Cellular energy is the plain-language term for how your cells convert food and oxygen into a usable power source. MOTS-c is a peptide researchers are studying in that process. It was previously not available at telos rx and is now offered after provider review. Here is what cellular energy actually means and where this specific peptide fits into that picture.
MOTS-c was previously not part of the telos rx program. It is now offered as a compounded subcutaneous injection after an online intake reviewed by a US-licensed provider, who sets the dose and schedule; see the MOTS-c page. This article explains the biology in plain terms, not a sales pitch. telos rx also offers a compounded NAD+ nasal spray, alongside BPC-157, PT-141, and sermorelin.
What cellular energy actually means
Every cell in your body needs a constant supply of a molecule called ATP to function. Muscles need it to contract, neurons need it to fire, and organs need it simply to keep running. Producing that ATP is the entire job of mitochondria, the small structures inside almost every cell that are often described as its power plants.
When people talk about feeling low on cellular energy, they are usually describing something that traces back to how well this production line is working. Poor sleep, aging, and certain health conditions can all affect mitochondrial output. That is one reason mitochondrial biology has become such an active research area well beyond academic circles.
It is worth being clear up front: no peptide or supplement can rebuild damaged mitochondria overnight, and any claim that suggests otherwise deserves skepticism regardless of the source. Real changes to mitochondrial health tend to happen gradually, through consistent habits, not a single injection or capsule.
Where MOTS-c fits into this picture
MOTS-c is a short peptide, only sixteen amino acids, and what makes it interesting to researchers is where it comes from. It is encoded inside mitochondrial DNA itself, rather than the much larger set of instructions stored in the cell's nucleus. That makes it one of a small group of molecules called mitochondrial-derived peptides.
Researchers have proposed that MOTS-c acts as a kind of messenger, carrying information from the mitochondria back to the nucleus about the cell's energy status. If that turns out to be accurate in humans at a meaningful scale, it would be a genuinely interesting piece of how cells regulate their own energy production.
telos rx previously did not offer MOTS-c. It now prescribes compounded MOTS-c after provider review. You can read how that works on the MOTS-c page.
Key takeaway: Mitochondria produce the energy your cells run on, and MOTS-c is a peptide researchers are studying as a possible signal within that system. Studying is not the same as an established, usable therapy.
What the research has actually shown
Published work on MOTS-c includes cell-based experiments and animal studies looking at metabolism, insulin sensitivity, and how circulating levels shift with exercise. That is a real and active line of research, and it is why MOTS-c keeps coming up in fitness and longevity conversations online.
What it does not include, at least not yet, is a large, well-controlled body of human evidence establishing a specific effect, dose, or safety profile for people using it as a treatment. That gap between cell and animal research on one hand, and confirmed human outcomes on the other, is exactly where a lot of online hype tends to outrun the actual science.
For general background on how the FDA evaluates and regulates compounded medications, see the FDA overview of drug compounding.
Why "energy peptide" claims deserve caution
MOTS-c is frequently marketed online with energetic, upbeat language about vitality and metabolism. Some of that framing borrows real scientific vocabulary, which can make it sound more settled than it is.
A useful habit is separating the mechanism from the outcome. Mitochondrial-nuclear signaling is a real biological phenomenon under study. Whether raising MOTS-c levels in a healthy adult meaningfully changes how that person feels day to day is a much bigger claim. It is also a far less settled one, and not one telos rx makes, even now that it offers MOTS-c.
General guidance from the NIH on evaluating unregulated health products, in using dietary supplements wisely, applies well here even though MOTS-c is not technically a supplement. The core idea, that marketing language and scientific evidence are not the same thing, holds regardless of category.
Why telos rx waited, and what changed
When this article was first written, telos rx was reviewing MOTS-c along with several other research peptides and did not offer it. A July 2026 review by the FDA's Pharmacy Compounding Advisory Committee produced non-binding recommendations touching several research peptides, MOTS-c included.
That recommendation did not add MOTS-c to any pharmacy's compounding program on its own, telos rx included. A recommendation from an advisory committee is a step in a longer regulatory process, not the end of one.
On October 28, 2026, HHS announced an interim enforcement discretion policy that includes MOTS-c. Under it, HHS does not intend to take enforcement action against state-licensed pharmacies that compound single-ingredient MOTS-c for subcutaneous or intramuscular injection with a valid prescription, as long as strict sourcing, testing and reporting conditions are met. It is temporary while FDA decides through rulemaking, it is not FDA approval, and HHS can revisit it. With that policy in place, telos rx added MOTS-c, offered after provider review.
Compounded medications in general, including the ones telos rx offers, are not FDA-approved. Adding a new peptide to the program is a separate decision from that baseline fact, and each MOTS-c prescription still depends on a provider's review of your intake.
Your options today
If the underlying interest is genuinely about cellular energy and how you feel day to day, you can now start a MOTS-c intake. telos rx also offers a compounded NAD+ nasal spray. NAD+ is a molecule directly involved in the same energy-producing pathways that mitochondria run. It comes with a real clinical intake rather than an unverified online purchase.
NAD+ itself has its own research history, separate from MOTS-c, and its own honest limitations. It is a separate protocol from MOTS-c, and a provider can help you decide which, if either, fits.
If BPC-157 is already part of your routine, adding NAD+ is a separate decision with its own intake, not an automatic bundle. A provider can talk through whether it makes sense alongside anything else you are already doing.
That is a different protocol than MOTS-c, built around a different molecule, and it is worth being upfront about that distinction rather than blurring the two together. If MOTS-c fits what you are looking for, you can start an intake for MOTS-c.
How mitochondria actually decline, in plain terms
Mitochondrial function does tend to change with age, and that is part of why the topic attracts so much attention. Cells accumulate wear over time, and the efficiency of energy production can drop as a result, which is a well-documented pattern in the aging research literature broadly.
What is far less settled is whether any single peptide can meaningfully reverse that pattern in a healthy person, at a dose and safety profile that has actually been established. That question mark still hangs over MOTS-c, even now that it is offered by prescription, and it is worth sitting with rather than skipping past.
Sleep, physical activity, and general metabolic health all interact with mitochondrial function in ways that are far better established than any single peptide's effect. Those fundamentals are worth prioritizing regardless of what happens with newer research compounds.
How to keep researching responsibly
If you want to keep learning about MOTS-c, primary literature is more reliable than summaries written for engagement. Searching MOTS-c directly on a database like PubMed will surface the original studies, including their sample sizes and whether the work was done in cells, animals, or people.
Reading the actual methods and limitations sections, not just an abstract, is the single best way to calibrate how confident any specific claim should make you feel. That habit serves you well for any peptide, not just this one.
It is also worth noticing who is making a given claim. A peer-reviewed study with a clearly described methodology carries more weight than a product listing or a social media post, even when both cite the same underlying biology. A vendor's website is not a substitute for reading the study it is quoting, and the two often say quite different things once you actually compare them.
Frequently Asked Questions
What is cellular energy, in plain terms?
It refers to how your cells convert food and oxygen into ATP, the molecule that powers nearly everything a cell does. Mitochondria are the structures responsible for most of that conversion.
Does MOTS-c increase cellular energy?
Research has studied MOTS-c in relation to metabolism and mitochondrial signaling, mostly in cells and animals. There is not an established, confirmed human effect that would support a direct claim like that.
Is MOTS-c the same thing as NAD+?
No. They are different molecules studied in overlapping areas of cellular energy research. Both are now offered at telos rx after provider review: NAD+ as a compounded nasal spray and MOTS-c as a compounded subcutaneous injection.
Does telos rx compound MOTS-c now?
Yes. MOTS-c was previously not available, but telos rx now prescribes compounded MOTS-c as a subcutaneous injection after an online intake reviewed by a US-licensed provider. A prescription is required and approval is not guaranteed.
Is MOTS-c FDA-approved?
No. Compounded medications generally are not FDA-approved, and that includes MOTS-c. telos rx offers it after provider review under a temporary HHS policy, which is not FDA approval.
What should I do if I want cellular energy support today?
You can start an online intake for MOTS-c, or for compounded NAD+ nasal spray, which targets a related pathway. A US-licensed provider reviews your answers and decides what fits.
telos rx is LegitScript-certified. Compounded medications are not FDA-approved. MOTS-c is offered by telos rx only by prescription, after provider review. This article is general information, not medical advice, and does not replace guidance from your own provider.
Ready to see if MOTS-c fits? Start with the MOTS-c page or learn about NAD+ nasal spray.